Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Conditions: Non Hodgkin Lymphoma

Interventions: Other: Long-term Follow-Up

Sponsors: Miltenyi Biomedicine GmbH


Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

November 5, 2023Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine